Moderna, Inc. vs Southern Copper Corp — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while Southern Copper Corp trades at $187.95 (market cap $146.07B). The key difference: Southern Copper Corp is far larger — about 6.2× Moderna, Inc.'s market cap, and Southern Copper Corp pays a 2.28% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | SCCO | |
|---|---|---|
Market Cap | $23.60B | $146.07B |
Sector | Health | Basic Materials |
52-Week High | $81.80 | $218.85 |
52-Week Low | $22.36 | $90.54 |
Enterprise Value | $19.70B | $148.12B |
Dividend Yield | — | 2.28% |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →